Cours Eidos Therapeutics, Inc.
Actions
EIDX
US28249H1041
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 01/03/16 |
Jonathan Fox
PSD | President | 67 | 01/10/16 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/21 |
Jonathan Fox
PSD | President | 67 | 01/10/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,73 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |